Certara will participate in 10 seminars and forums, launch the new version of its Phoenix PK/PD software platform, and support the National Organization for Rare Disorders during the show. PRINCETON, NJ – Oct. 31, 2014 – Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced that its Simcyp® and Pharsight® consultants … Continued
Enhanced solution will be able to model additional populations, and diseases, and also consider new mechanisms that impact dermal absorption. ST. LOUIS, MO – Oct. 23, 2014 – Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced that it has received a Food and Drug Administration (FDA) Office of Generic Drugs … Continued
User Group Meeting “Highly Informative and Incredibly Valuable,” Says D360 Clients ST. LOUIS, MO – Oct. 17, 2014 – Certara’s Second Annual D360™ User Group Meeting (UGM) was described as “Highly Informative” and “Incredibly Valuable” by top pharmaceutical scientists who attended. The meeting, held at the Boston’s Royal Sonesta Hotel on October 8 and 9, … Continued
